Fengxia Zhang

Ganzhou, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

m6A RNA methylation regulator heterogeneous nuclear ribonucleoprotein C: A prognostic biomarker for invasive ductal carcinoma validated through Mendelian randomization and transcriptome analyses.

m6A RNA methylation regulator heterogeneous nuclear ribonucleoprotein C: A prognostic biomarker for invasive ductal carcinoma validated through Mendelian randomization and transcriptome analyses.

Journal: Medicine
Published: May 14, 2025

Identification of podocyte molecular markers in diabetic kidney disease via single-cell RNA sequencing and machine learning.

Identification of podocyte molecular markers in diabetic kidney disease via single-cell RNA sequencing and machine learning.

Journal: PloS one
Published: April 09, 2025

Integrated multi-omics analysis describes immune profiles in ischemic heart failure and identifies PTN as a novel biomarker.

Integrated multi-omics analysis describes immune profiles in ischemic heart failure and identifies PTN as a novel biomarker.

Journal: Frontiers in molecular biosciences
Published: November 08, 2024

Single-nucleus RNA sequencing reveals ARHGAP28 expression of podocytes as a biomarker in human diabetic nephropathy.

Single-nucleus RNA sequencing reveals ARHGAP28 expression of podocytes as a biomarker in human diabetic nephropathy.

Journal: Open medicine (Warsaw, Poland)
Published: October 01, 2024

Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis.

Micheliolide ameliorates lipopolysaccharide-induced acute kidney injury through suppression of NLRP3 activation by promoting mitophagy via Nrf2/PINK1/Parkin axis.

Journal: International immunopharmacology
Published: March 10, 2024

The risk factor for adverse pregnancy outcomes and its impact on clinical effect in IgA nephropathy: A retrospective observational study.

The risk factor for adverse pregnancy outcomes and its impact on clinical effect in IgA nephropathy: A retrospective observational study.

Journal: Nephrology (Carlton, Vic.)
Published: January 05, 2024

Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.

Metastasis, characteristic, and treatment of breast cancer in young women and older women: A study from the Surveillance, Epidemiology, and End Results registration database.

Journal: PloS one
Published: August 29, 2023

N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.

N6-methyladenosine methylation regulator RBM15 promotes the progression of diabetic nephropathy by regulating cell proliferation, inflammation, oxidative stress, and pyroptosis through activating the AGE-RAGE pathway.

Journal: Environmental toxicology
Published: March 30, 2023

Immune-related SERPINA3 as a biomarker involved in diabetic nephropathy renal tubular injury.

Immune-related SERPINA3 as a biomarker involved in diabetic nephropathy renal tubular injury.

Journal: Frontiers in immunology
Published: June 28, 2022

Fate decisions of breast cancer stem cells in cancer progression.

Fate decisions of breast cancer stem cells in cancer progression.

Journal: Frontiers in oncology
Published: June 13, 2022

Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis.

Effects of Uremic Clearance Granules on p38 MAPK/NF-κB Signaling Pathway, Microbial and Metabolic Profiles in End-Stage Renal Disease Rats Receiving Peritoneal Dialysis.

Journal: Drug design, development and therapy
Published: March 02, 2022

Single cell sequencing coupled with bioinformatics reveals PHYH as a potential biomarker in kidney ischemia reperfusion injury.

Single cell sequencing coupled with bioinformatics reveals PHYH as a potential biomarker in kidney ischemia reperfusion injury.

Journal: Biochemical and biophysical research communications
Published: February 09, 2022
Showing 1-12 of 12

Last Updated: 09/26/2026